Management of overactive bladder in women

被引:0
作者
Peyronnet, B. [1 ]
Rigole, H. [2 ]
Damphousse, M. [2 ]
Manunta, A. [1 ]
机构
[1] Hop Pontchaillou, Serv Urol, F-35000 Rennes, France
[2] CHU Rennes, Serv Med Phys & Reeduc, F-35000 Rennes, France
来源
PROGRES EN UROLOGIE | 2015年 / 25卷 / 14期
关键词
URINARY; TERMINOLOGY;
D O I
10.1016/j.purol.2015.05.014
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Overactive bladder (OAB) is defined as urgency, with or without urge incontinence, usually with frequency and nocturia. OAB has been reported in 9 to 43% of female patients. It is usually idiopathic. The diagnosis is clinical but an initial work-up may be needed to exclude an underlying cause (bladder tumor, stone, cystitis, neurological disorder...) using urinary tract ultrasound, urine culture or cystoscopy. The initial assessment may also include a frequency-volume chart and urodynamics. Behavioral therapy is the first line treatment. In case of failure, antimuscarinics are recommended. Nowadays, three treatment options are available for OAB refractory to antimuscarinics: sacral neuromodulation, peripheral tibial nerve stimulation and intra-detrusor injections of botulinum toxin. Surgical procedures such as augmentation cystoplasty are very rarely required. (C) 2015 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:877 / 883
页数:7
相关论文
共 12 条
[1]  
Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052
[2]   Translation and linguistic validation in classical Arabic of the Urinary Symptom Profile (USP) questionnaire [J].
Arabi, H. ;
Bendeddouche, I. ;
Khalfaoui, S. ;
Louardi, N. ;
Ameur, A. ;
Lebreton, F. ;
Amarenco, G. .
PROGRES EN UROLOGIE, 2013, 23 (04) :244-248
[3]   Guidelines for the treatment of urinary incontinence in women with refractory idiopathic vesical hyperactivity using sacral neuromodulation [J].
Cardot, V. ;
Berlizot, P. ;
Le Normand, L. .
PROGRES EN UROLOGIE, 2010, 20 :S161-S169
[4]   Urinary bladder drugs [J].
Caremel, R. ;
Cornu, J. -N. ;
Kerdraon, J. ;
Castel-Lacanal, E. ;
Bastide, C. ;
Bruyere, F. ;
Guy, L. ;
Karsenty, G. .
PROGRES EN UROLOGIE, 2013, 23 (15) :1271-1286
[5]   Pharmacological treatment of idiopathic overactive bladder: A literature review [J].
Cornu, J. -N. ;
Haab, F. .
PROGRES EN UROLOGIE, 2013, 23 (04) :227-236
[6]   Pelvic floor rehabilitation for female urinary incontinence: Mechanisms of action [J].
Deffieux, X. ;
Billecocq, S. ;
Demoulin, G. ;
Rivain, A. -L. ;
Trichot, C. ;
Thubert, T. .
PROGRES EN UROLOGIE, 2013, 23 (08) :491-501
[7]  
Game X, 2015, PROG UROL
[8]   Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline [J].
Gormley, E. Ann ;
Lightner, Deborah J. ;
Burgio, Kathryn L. ;
Chai, Toby C. ;
Clemens, J. Quentin ;
Culkin, Daniel J. ;
Das, Anurag Kumar ;
Foster, Harris Emilio, Jr. ;
Scarpero, Harriette Miles ;
Tessier, Christopher D. ;
Vasavada, Sandip Prasan .
JOURNAL OF UROLOGY, 2012, 188 (06) :2455-2463
[9]  
Haab F, 2004, PROG UROL, V14, P1103
[10]   Guidelines for practical usage of botulinum toxin type A (BoNTA) for refractory idiopathic overactive bladder management [J].
Hermieu, J. -F. ;
Ballanger, P. ;
Amarenco, G. ;
Chartier-Kastler, E. ;
Cosson, M. ;
Costa, P. ;
Fatton, B. ;
Deffieux, X. ;
Denys, P. ;
Game, X. ;
Haab, F. ;
Karsenty, G. ;
Le Normand, L. ;
Ruffion, A. ;
Saussine, C. .
PROGRES EN UROLOGIE, 2013, 23 (17) :1457-1463